R Fey1, N Pearson. Show Affiliations » 1. Avon Health (Avon Family Health Service Authority, Bristol, UK.
Abstract
Entities: Disease
Mesh: See more » AgedAnticholesteremic Agents/economicsAnticholesteremic Agents/therapeutic useCholesterol/bloodCoronary Disease/prevention & controlEnzyme Inhibitors/economicsEnzyme Inhibitors/therapeutic useFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHydroxymethylglutaryl-CoA-Reductases, NADP-dependentMaleMiddle AgedPravastatin/economicsPravastatin/therapeutic useRandomized Controlled Trials as TopicRisk Factors
Substances: See more » Anticholesteremic AgentsEnzyme InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsCholesterolHydroxymethylglutaryl-CoA-Reductases, NADP-dependentPravastatin
Year: 1996 PMID: 8637349 DOI: 10.1016/s0140-6736(96)91019-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321